Replies to post #4810 on Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

The only problem with all these HALO partnered drugs as well as PEG and possible new indications for Hylenex is that we are talking about 2020 approvals. In the meantime disappointing royalties will not be sufficient to cover the huge costs of ongoing trials. We desperately need great PEG Phase 2 data news but that's unlikely.